DE60203599D1 - Methode zur Inaktivierung von TSE - Google Patents

Methode zur Inaktivierung von TSE

Info

Publication number
DE60203599D1
DE60203599D1 DE60203599T DE60203599T DE60203599D1 DE 60203599 D1 DE60203599 D1 DE 60203599D1 DE 60203599 T DE60203599 T DE 60203599T DE 60203599 T DE60203599 T DE 60203599T DE 60203599 D1 DE60203599 D1 DE 60203599D1
Authority
DE
Germany
Prior art keywords
tse
inactivating
inactivating tse
infected
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE60203599T
Other languages
English (en)
Other versions
DE60203599T2 (de
Inventor
Neil D H Raven
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Health Protection Agency
Original Assignee
Health Protection Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26245535&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60203599(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0100420A external-priority patent/GB0100420D0/en
Priority claimed from GB0104696A external-priority patent/GB0104696D0/en
Application filed by Health Protection Agency filed Critical Health Protection Agency
Publication of DE60203599D1 publication Critical patent/DE60203599D1/de
Application granted granted Critical
Publication of DE60203599T2 publication Critical patent/DE60203599T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/22—Phase substances, e.g. smokes, aerosols or sprayed or atomised substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00—Disinfection, sterilisation or deodorisation of air
    • A61L9/015—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone
    • A61L9/02—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air by heating or combustion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2872—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against prion molecules, e.g. CD230
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • C11D3/38618—Protease or amylase in liquid compositions only
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Enzymes And Modification Thereof (AREA)
DE60203599T 2001-01-08 2002-01-08 Methode zur Inaktivierung von TSE Revoked DE60203599T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0100420 2001-01-08
GB0100420A GB0100420D0 (en) 2001-01-08 2001-01-08 Degradation of TSE and similar agents
GB0104696A GB0104696D0 (en) 2001-02-26 2001-02-26 Degradation of tse and similar agents
GB0104696 2001-02-26
PCT/GB2002/000052 WO2002053723A2 (en) 2001-01-08 2002-01-08 Degradation and detection of tse infectivity

Publications (2)

Publication Number Publication Date
DE60203599D1 true DE60203599D1 (de) 2005-05-12
DE60203599T2 DE60203599T2 (de) 2006-01-19

Family

ID=26245535

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60203599T Revoked DE60203599T2 (de) 2001-01-08 2002-01-08 Methode zur Inaktivierung von TSE

Country Status (10)

Country Link
EP (2) EP1577382A3 (de)
JP (2) JP4427252B2 (de)
AT (1) ATE292679T1 (de)
AU (1) AU2002219336C1 (de)
CA (1) CA2434129A1 (de)
DE (1) DE60203599T2 (de)
ES (1) ES2237675T3 (de)
HK (1) HK1057062A1 (de)
PT (1) PT1360282E (de)
WO (1) WO2002053723A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7303907B2 (en) 2001-01-08 2007-12-04 Health Protection Agency Degradation and detection of TSE infectivity
AUPR293801A0 (en) * 2001-02-07 2001-03-01 Novapharm Research (Australia) Pty Ltd Prion disinfection
EP1395833B1 (de) 2001-05-31 2013-02-27 Adlyfe, Inc. Verfahren zum erkennen von inkorrekt gefalteten proteinen
DE10203225A1 (de) 2002-01-28 2003-07-31 Weigert Chem Fab Reinigung chirurgischer Instrumente
EP1561807B1 (de) 2002-10-24 2010-12-01 Meiji Seika Kaisha Ltd. Abbauverfahren für ein schwer abbaubares protein
GB2394663B (en) * 2002-11-01 2006-07-12 Medical Res Council Prion decontamination
WO2004039418A1 (en) * 2002-11-01 2004-05-13 Medical Research Council Prion decontamination
GB0406427D0 (en) 2004-03-22 2004-04-21 Health Prot Agency Biological indicator
ATE528649T1 (de) 2005-02-15 2011-10-15 Adlyfe Inc Verfahren zum nachweis falsch gefalteter proteine und prionen
ES2534471T3 (es) 2006-10-27 2015-04-23 E.I. Du Pont De Nemours And Company Método para la descontaminación de priones
US7922970B2 (en) * 2007-04-03 2011-04-12 Kimberly-Clark Worldwide, Inc. Use of sonication to eliminate prions
US8293174B2 (en) 2007-10-17 2012-10-23 American Sterilizer Company Prion deactivating composition and methods of using same
WO2010021375A1 (ja) * 2008-08-22 2010-02-25 国立大学法人大阪大学 プロテアーゼの製造方法、並びにプロテアーゼ溶液およびプロテアーゼのプロ体溶液
CN102695722A (zh) * 2009-03-02 2012-09-26 不列颠哥伦比亚大学 对错误折叠的朊病毒蛋白具有特异性的抗体和表位
EP2311323B1 (de) * 2009-10-19 2013-01-16 Univerza v Ljubljani Abbaumethoden von Proteinablagerungen und Prionen
WO2017172879A1 (en) 2016-03-29 2017-10-05 Oneighty°C Technologies Corporation Method for rapidly determining effective sterilization, demmunization, and/or disinfection

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3042860A1 (de) * 1980-11-13 1982-06-09 Heyl & Co Chemisch-Pharmazeutische Fabrik, 1000 Berlin Kollagenpraeparate, verfahren zu ihrer herstellung und ihre verwendung in der human- und veterinaermedizin
US4614549A (en) * 1983-10-24 1986-09-30 Bausch & Lomb Incorporated Method for enzymatic cleaning and disinfecting contact lenses
US5223166A (en) * 1986-11-17 1993-06-29 Henkel Kommanditgesellschaft Auf Aktien Preparations and processes for cleaning and disinfecting endoscopes
DE3816734A1 (de) * 1988-05-17 1989-11-30 Henkel Kgaa Verfahren zur reinigung und desinfektion von hitze- und korrosionsempfindlichen medizinischen geraeten, insbesondere von endoskopen und mittel zur durchfuehrung des verfahrens
SI0730024T1 (en) * 1995-03-01 2000-02-29 Chemische Fabrik Dr. Weigert (Gmbh & Co.) Surgical instruments cleaning composition
BR9707223A (pt) * 1996-01-29 1999-12-28 Charles Doillon Produtos de colágeno e derivados de colágeno isentos de prìon e implantes para múltiplas aplicações biomédicas ; métodos de obtenção dos mesmos
DE19730132C2 (de) * 1997-07-14 2000-01-20 Fraunhofer Ges Forschung Verfahren zum Nachweis von Prionen sowie eine Vorrichtung hierzu
US20020192731A1 (en) * 2001-04-12 2002-12-19 H. Shih Jason C. Method and composition for sterilizing surgical instruments
DE60121729T2 (de) * 2001-04-19 2007-11-29 Dr. Hermann Schätzl Prion Proteindimere für Impfungen

Also Published As

Publication number Publication date
PT1360282E (pt) 2005-06-30
CA2434129A1 (en) 2002-07-11
EP1360282B1 (de) 2005-04-06
ES2237675T3 (es) 2005-08-01
HK1057062A1 (en) 2004-03-12
WO2002053723B1 (en) 2003-02-13
EP1360282A2 (de) 2003-11-12
DE60203599T2 (de) 2006-01-19
EP1577382A3 (de) 2006-08-30
AU2002219336B2 (en) 2005-04-14
AU2002219336C1 (en) 2008-08-14
ATE292679T1 (de) 2005-04-15
JP2004516845A (ja) 2004-06-10
WO2002053723A2 (en) 2002-07-11
EP1577382A2 (de) 2005-09-21
WO2002053723A3 (en) 2002-12-12
JP4427587B2 (ja) 2010-03-10
JP2008174568A (ja) 2008-07-31
JP4427252B2 (ja) 2010-03-03

Similar Documents

Publication Publication Date Title
DE60203599D1 (de) Methode zur Inaktivierung von TSE
ATE385259T1 (de) Verfahren zum nachweis von influenza a/b-viren in speichel
ATE412774T1 (de) Parallele genotypisierung mehrerer patientenproben
ATE466659T1 (de) Probenahmesystem mit phosphataseinhibitor
DE60223668D1 (de) Kit zur messung von blutzuckerkonzentrationen
HK1118044A1 (en) Dimeric iap inhibitors iap
ATE289685T1 (de) Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben
ATE498134T1 (de) Nachweis von staphylococcus
NO20052992L (no) Markorproteiner for diagnostisering av leversykdom og fremgangsmate for diagnostisering av leversykdom.
CY1112423T1 (el) Αναλυτικη συσκευη μικροεπεξεργαστη μιας χρησης
CY1111371T1 (el) Αντισωματα bag3 για χρηση σε ερευνα, διαγνωση και θεραπεια ασθενειων που σχετιζονται με κυτταρικο θανατο
ATE545460T1 (de) Proteomanalyseverfahren für phosphoryliertes protein
DE602006015330D1 (de) Nachweis und messung einer blutzuführungsaktivität
CY1105025T1 (el) Αναλυση λεπτινης βασιζομενη στην ανιχνευση εκφρασης ang-2
GB2437545B (en) Dextrin-containing reagents for detecting and quantifying proteins
GB0805608D0 (en) Detection method
BR0314155A (pt) Métodos para diagnosticar câncer cervical
DE602006015702D1 (de) Unterscheidung zwischen baktiereller meningitis und viraler meningitis
NO20006109D0 (no) Analytisk metode som beskytter multippel virusmerking
ATE493432T1 (de) Gewinnung von hitzeschockproteinen
ATE426168T1 (de) Verwendung von asc als marker fur kolorektalkarzinome
DE50101520D1 (de) Kompetitives assay-verfahren
BR0213997A (pt) Métodos de detecção e identificação de bactérias entéricas
ATE555385T1 (de) N1,n12-diacetylspermin als tumormarker
DE602005023784D1 (de) Blockierter enzymsondenkomplex

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation